Newest Omicron lineages gaining ground in the U.S.; Francis Collins talks his new White House role

The United States appears to be in the midst of another biological baton pass between Covid-19 variants. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      Newest Omicron Covid-19 lineages gaining ground in United States By Andrew Joseph Jae C. Hong/AP The United States appears to be in the midst of another biological baton pass between Covid-19 variants, now to BA.4 and BA.5. Read More STAT+: The FTC says it's getting tougher on hospital consolidation. Antitrust experts aren't buying it By Tara Bannow SAUL LOEB/POOL/AFP via Getty Images Antitrust experts say the FTC’s recent hospital merger challenges don’t show a tougher approach to health care consolidation. Read More Francis Collins on his new life as White House science adviser By Lev Facher Bill Clark/CQ Roll Call/AP Francis Collins thought he'd get some peace and quiet after 12 years running the NIH. Then came a plea from the president. Read More Sponsor content by Infectious Diseases Society of America Pride 2022 – Promoting equity in COVID-19 response and treatment The Covid-19 Real-Time Learning Network's Health Equity Resources are carefully curated to support clinicians in the ongoing battles against Covid-19 and enable them to provide the best possible care to all patients. Created with funding from CDC, it offers training and informational materials on health inequities, cultural awareness, vaccine education, and more. Visit the Infectious Diseases Society of America's Covid-19 Real-Time Learning Network for the latest in providing equitable, culturally-informed Covid-19 care. STAT+: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb By Rachel Cohrs J. Scott Applewhite/AP They want the FTC to investigate whether Janssen and Bristol Myers Squibb coordinated price hikes for two blockbuster blood thinners. Read More STAT+: Amylyx's case for approval of its ALS drug isn't ironclad. Here's why I think it will still happen By Adam Feuerstein Molly Ferguson/STAT The evidence supporting the approval of Amylyx's Albrioza approval isn't ironclad, but it’s stronger than the equivocal data used to approve Aduhelm. Read More Opinion: The irony — and ignominy — of medical conferences as superspreader events By Anand Swaminathan and Jessica Smith and Esther Choo Adobe Emergency physicians have seen the worst of Covid-19, so you might expect them to be careful when attending conferences. You'd be wrong. Read More WHO to convene emergency committee on monkeypox spread By Helen Branswell FABRICE COFFRINI/AFP via Getty Images The panel will advise WHO on whether the current spread of monkeypox constitutes a public health emergency of international concern. Read More STAT+: A widely anticipated ALS drug wouldn't be cost effective if priced the same as an older rival By Ed Silverman Adobe "This could still be a garbage-in garbage-out issue," said Neil Thakur of the ALS Association about the quality of the data in the analysis. Read More Tuesday, June 14, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser